Article | 7/5/2023

Starlight Cardiovascular’s Right-Sized Neonatal Stent for Congenital Heart Defects

MedTech Strategist
By Susan Posner and Masha Dumanis

Starlight Cardiovascular is an early-stage company focused on innovative products to solve challenging issues in neonatal care. The company is currently designing and developing a stent for the ductus arteriosus of neonates. Health Advances interviewed the co-founder and CEO of Starlight Cardiovascular, Beverly Tang, PhD, and VP of strategic and product marketing, Kathryn Olson, to discuss their journey, the company’s progress to date, and their advice for pediatric device entrepreneurs.

Read here.

Share this: